tiopronin has been researched along with Anemia, Sickle Cell in 2 studies
Tiopronin: Sulfhydryl acylated derivative of GLYCINE.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Udupi, V | 1 |
| Rice-Evans, C | 1 |
| Lachant, NA | 1 |
| Tanaka, KR | 1 |
1 trial available for tiopronin and Anemia, Sickle Cell
| Article | Year |
|---|---|
Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Anemia, Sickle Cell; Antioxidants; Ascorbic Acid; Clinical Tri | 1986 |
1 other study available for tiopronin and Anemia, Sickle Cell
| Article | Year |
|---|---|
Thiol compounds as protective agents in erythrocytes under oxidative stress.
Topics: Acetylcysteine; Anemia, Sickle Cell; Antioxidants; Erythrocytes; Humans; Oxidation-Reduction; Thioma | 1992 |